Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
about
Management of antipsychotic-related weight gainGenetics of antipsychotic treatment emergent weight gain in schizophrenia.The impact of hyperactivity and leptin on recovery from anorexia nervosa.A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychoticsOlanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis.Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.Antipsychotic induced weight gain in schizophrenia:mechanisms and management.Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary EvidenceHormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.Atypical antipsychotic-induced weight gain: insights into mechanisms of action.Effects of weight loss diet therapy on anthropometric measurements and biochemical variables in schizophrenic patients.Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes.Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.Plasma leptin and antipsychotic-induced body weight gain.Sex Differences in Leptin Control of Cardiovascular Function in Health and Metabolic Diseases.Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics
P2860
Q24610124-DBD450D8-9678-4D45-B1E7-615DAD0953F9Q33257886-79D426B8-9B1D-46EC-ADEC-54DD1C4570C4Q33560869-A43939FA-9AAF-4D1A-9267-02F1546FC29BQ33888821-BA0F3AB0-1F47-4710-8EA0-8CF90B915337Q33942644-E95B04CB-EAF9-401F-8BEB-C7CAC1F79E40Q34056408-9F5054AF-AAB7-4015-A0EA-72703F7C8229Q34197980-4256AE53-FBC6-4AA3-9A09-61D8725AFB8AQ35156543-BB5ACA82-B63F-446F-A8DE-E8FC123BF30CQ35566086-91AFAEEA-5E48-4448-82F2-D41B74FFEA23Q37047473-B35E8873-1BFB-4A01-8242-D9D1599F4B45Q37060706-C45545EA-C2B6-4F1E-AE4D-C36FB7372C34Q37160453-476E81F9-D1FA-4CCA-853B-7031F1431331Q37178192-A1EF27A7-A574-4D26-91F5-CE02AB7978C1Q37387054-68DE8DA7-06E6-422A-BF9D-0AA73EF7C459Q37963571-1E5A10D1-37D7-4499-AB50-9E56D0DE4BFEQ41733975-C072B7D3-826D-4AB7-A790-71711E776F19Q46444830-1F04ABC0-A912-4A59-8619-D65A1BCEF34EQ47302385-98C561BA-A612-469F-8499-0998C708FBA7Q47303990-D45400DF-BBF2-4BAF-853B-D31847512FA6Q47371630-9614B9A5-808B-4BD8-992D-1617DC66A293Q49971662-39624C7A-EA9D-492E-9FD3-D404053B28D2Q54662194-5DA081A8-29EF-4B24-BD5D-9575E6132A7CQ59206898-1B07AEC5-0ECC-4AED-A856-9E992A540D7A
P2860
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@en
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@nl
type
label
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@en
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@nl
prefLabel
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@en
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@nl
P2093
P2860
P356
P1476
Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
@en
P2093
Angela K Melson
Angela Luber
Dan W Haupt
John W Newcomer
Julie A Schweiger
Justin Maeda
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300563
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1033460609